Capital Group Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.71M | Sell |
7,065
-1,860
| -21% | -$977K | 0.66% | 49 |
|
|
2025
Q1 | $5.66M | Buy |
8,925
+182
| +2% | +$115K | 1.16% | 24 |
|
|
2024
Q4 | $6.23M | Buy |
8,743
+1,275
| +17% | +$908K | 1.18% | 22 |
|
|
2024
Q3 | $7.85M | Buy |
7,468
+31
| +0.4% | +$32.6K | 1.58% | 14 |
|
|
2024
Q2 | $7.82M | Sell |
7,437
-702
| -9% | -$738K | 1.69% | 13 |
|
|
2024
Q1 | $7.83M | Sell |
8,139
-5,453
| -40% | -$5.25M | 1.4% | 14 |
|
|
2023
Q4 | $11.9M | Sell |
13,592
-12,127
| -47% | -$10.7M | 1.25% | 17 |
|
|
2023
Q3 | $21.2M | Sell |
25,719
-3,630
| -12% | -$2.99M | 1.38% | 17 |
|
|
2023
Q2 | $21.1M | Buy |
29,349
+1,444
| +5% | +$1.04M | 1.05% | 29 |
|
|
2023
Q1 | $22.9M | Sell |
27,905
-13,416
| -32% | -$11M | 1.23% | 21 |
|
|
2022
Q4 | $29.8M | Buy |
+41,321
| New | +$29.8M | 1.15% | 29 |
|